Get notified when ZSQR files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsCritical incident detected
Fraud / investigation
Time-sensitive event — see the red-flag panel below for the source-quoted detail.
Red Flags Detected
- Key Supplier Under Sec Investigation (new) — BSG Series CM, the company's mining asset supplier, faces SEC litigation and court-ordered monitoring, creating counterparty risk.
Z Squared completes reverse merger, pivots from biopharma to Dogecoin/Litecoin mining
Filed April 30, 2026 · Period ending April 24, 2026 · ~1 min read
Key Changes
-
high
Coeptis Therapeutics completed reverse merger with Z Squared Inc. on April 24, 2026. Former Z Squared shareholders received 43.9M shares representing majority control. Company changed name to Z Squared Inc. (ticker: ZSQR) and will report Z Squared's historical financials going forward.
Item 2.01 verify on EDGAR → -
high
Business transformed from biopharmaceuticals to cryptocurrency mining focused on Dogecoin and Litecoin. Will deploy 9,800 ASIC miners across six North American facilities with mining assets valued at $660.3M as of January 2025.
Item 2.01: Business Description verify on EDGAR → -
high
Entire board and executive team replaced at closing. New CEO David Halabu and four other Z Squared designees now control governance. Former Coeptis management resigned.
Item 5.01, 5.02 verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade ZSQR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 2, 2026 · How we verify